If CPAP masks or oral appliances haven’t controlled your sleep apnea, a jaw-advancement surgery called maxillomandibular advancement (MMA) may be worth discussing with your care team. A recent case report does not present new efficacy data, but it does highlight that MMA — despite efficacy figures reported in the literature it cites and its recognition in treatment guidelines — appears to be used less often than the evidence would support.
Key Points
- Maxillomandibular advancement (MMA) is a surgery that moves the upper and lower jaw forward to enlarge the airway behind the tongue and soft palate.
- It’s generally considered for obstructive sleep apnea (OSA) after CPAP or a mandibular advancement device hasn’t worked or hasn’t been tolerated.
- A recent case report cites supporting literature reporting average AHI reductions exceeding 50%; whether a given patient reaches AHI values in the normal range depends on which surgical success/cure definition is used, and this is not something the case report itself quantifies ([PMID 42593027]).
- The same report’s central finding is that MMA is used less often than treatment guidelines suggest it should be, despite efficacy data reported elsewhere in the literature.
- Candidacy depends on airway anatomy, jaw alignment, health status, and prior treatment history — not on OSA severity alone.
- MMA is major orthognathic (jaw) surgery with a documented complication and risk profile, and it changes facial profile — both are standard considerations in surgical counseling, addressed further below.
What Is Maxillomandibular Advancement?
Obstructive sleep apnea happens when soft tissue at the back of the throat collapses repeatedly during sleep, blocking airflow. Maxillomandibular advancement is a surgical procedure that moves the upper jaw (maxilla) and lower jaw (mandible) forward. Because the tongue and soft palate are anchored to these bones, moving the jaw bones forward pulls that soft tissue anteriorly, away from the back of the throat, enlarging the airway space where collapse most often occurs. This is an anatomic modification — it changes the underlying anatomy rather than holding the airway open each night with a device. Long-term stability of this skeletal result is itself a studied variable in the orthognathic surgery literature, not something that can be assumed to be fixed once achieved.
How Is It Diagnosed — and Who Is a Candidate?
MMA isn’t a first-line treatment. It’s considered after a formal diagnosis of OSA (typically via a sleep study measuring the AHI) and, usually, after other therapies have been tried:
- Confirm the diagnosis. A sleep study establishes OSA severity based on the AHI.
- Try first-line therapy. CPAP is the standard starting point; a mandibular advancement device (an oral appliance that holds the lower jaw forward) is another common option.
- Evaluate for surgery when first-line therapy fails. The case report describes MMA as an option for patients who have failed, or shown insufficient response to, CPAP or oral appliance therapy ([PMID 42593027]).
- Surgical work-up and planning. This includes clinical, occlusal (bite), and imaging evaluation of jaw and airway anatomy to determine feasibility and achievable movement, along with assessment of overall surgical fitness. In practice, candidacy evaluation for MMA commonly involves a staged process with presurgical orthodontic coordination and surgical planning that can extend over several months before the procedure itself, plus a postoperative recovery period — this workup burden is not detailed in the case report and should be discussed directly with the surgical and orthodontic team.
Patient selection criteria, specific comorbidity considerations, and how prior treatments affect timing of surgery are areas the current case report doesn’t fully detail — these are individualized decisions made with a sleep physician and oral/maxillofacial surgeon.
Which Treatment Is Right for Me?
| Option | What it does | Evidence base | Typically considered when |
|---|---|---|---|
| CPAP | Pneumatically holds the airway open with pressurized air, nightly | First-line standard of care | As initial therapy for most diagnosed OSA |
| Mandibular advancement device | Holds the lower jaw forward with an oral appliance during sleep | Well established for mild-moderate OSA; used more broadly | CPAP intolerance, or as an alternative first-line option |
| Maxillomandibular advancement (MMA) | Surgically advances both jaws to enlarge the airway | Average AHI reductions exceeding 50% reported in the literature cited by a recent case report; figures vary by study population and by success/cure definition used ([PMID 42593027]) | CPAP and/or oral appliance failure or intolerance |
The choice isn’t based on AHI severity alone. It depends on airway anatomy, jaw and bite relationships, prior response to non-surgical therapy, and the patient’s overall surgical candidacy — which is why this decision is made jointly with sleep medicine and surgical specialists, not from a sleep study number in isolation.
What the New Research Adds
The case report summarizes AHI outcomes from the literature it cites: an average reduction exceeding 50%, in some cases accompanied by improved quality-of-life measures ([PMID 42593027]). The sleep surgery literature commonly distinguishes surgical success (typically ≥50% AHI reduction with postoperative AHI below a defined threshold, e.g., 20/hr) from surgical cure (postoperative AHI in or near the normal range, e.g., below 5–10/hr); these are not the same outcome, and the case report does not report what proportion of patients meet each definition. This distinction should be discussed explicitly with patients rather than assumed.
The report’s central contribution is not new efficacy data but an observation about a gap between evidence and practice: it identifies underutilization of MMA in clinical settings despite the procedure’s recognition in international treatment guidelines. In other words, the efficacy figures it cites are drawn from prior literature, not generated by this report — but the underuse finding is its own observation. The report doesn’t address specific patient selection criteria, comorbidity profiles, timing of surgery relative to prior treatment, or a breakdown of the adverse event and complication profile from its own data.
Separately, MMA is well characterized in the broader oral and maxillofacial surgery literature as a major procedure with a documented complication profile, including risks such as inferior alveolar or infraorbital nerve paresthesia, changes in occlusion (bite), need for coordinated orthodontic treatment, and effects on the temporomandibular joint. Advancing both jaws also changes facial profile, an outcome domain that has itself been specifically studied. These considerations are not addressed by the case report’s abstract-level data but are established elsewhere in the surgical literature and are relevant to informed decision-making.
When to See a Specialist
Consider a referral to a sleep medicine or oral/maxillofacial surgery specialist if:
- CPAP hasn’t controlled your symptoms, or you can’t tolerate it despite multiple attempts at mask/fit adjustment.
- A mandibular advancement device hasn’t adequately reduced your AHI on follow-up sleep testing.
- You have jaw or bite characteristics that a dentist or sleep physician has flagged as relevant to airway anatomy.
- You want to understand whether a structural (surgical) option fits your case, including its expected effects on facial profile, its known complication risks, and the presurgical/orthodontic planning process, rather than continuing device-dependent therapy indefinitely.
For Referring Providers
MMA is recognized in treatment guidelines as a surgical option for OSA patients who have failed or inadequately responded to CPAP or mandibular advancement device therapy. A recent case report cites literature reporting average AHI reductions exceeding 50%, though the proportion of patients meeting surgical success versus surgical cure criteria is not specified in that report ([PMID 42593027]). The report’s principal finding is a practice gap — MMA appears underutilized relative to its guideline recognition — which may reflect limited referral pathways, surgical access, or patient/provider familiarity with the procedure rather than a deficiency in the evidence base.
The report does not detail patient selection criteria, comorbidity stratification, optimal timing relative to prior interventions, or a quantified complication profile. Separately from this source, MMA is established in the broader literature as major orthognathic surgery with a documented risk profile (e.g., neurosensory changes, occlusal changes, TMJ effects) and a studied effect on facial esthetics, as well as skeletal stability considerations over time. Presurgical workup typically involves staged orthodontic and surgical planning over several months. These factors should be addressed through direct surgical consultation and individualized work-up (clinical, occlusal, and imaging evaluation of jaw and airway anatomy) before treatment planning.
References
- [PMID 42593027] — Maxillomandibular advancement: case report and review of efficacy, guideline recognition, and clinical underutilization.
- Movahed R, Ivory JW, Delatour B. Complications Associated with Maxillomandibular Advancement. (Book chapter; cited for the general complication profile of MMA, not for outcome statistics reported above.)
- Facial esthetics and subjective impairment assessed after maxillomandibular advancement. (Cited for the facial esthetic outcome domain of MMA, not for outcome statistics reported above.)
- Arpornmaeklong P, et al. Skeletal stability following maxillary impaction and mandibular advancement. Int J Oral Maxillofac Surg. 2004. (Cited for the skeletal stability/relapse literature, not for outcome statistics reported above.)
